No­vo Nordisk an­tic­i­pates patchy We­govy sup­ply in the com­ing months as it pro­vides in­sight on man­u­fac­tur­ing plans

De­spite No­vo Nordisk ini­tial­ly sug­gest­ing its US sup­ply short­age for We­govy would ease in Sep­tem­ber, it is now say­ing such con­straints may car­ry on a bit longer.

The com­pa­ny had put on its web­site that US pa­tients may have dif­fi­cul­ty fill­ing their pre­scrip­tions for cer­tain dos­es of We­govy “through Sep­tem­ber.” How­ev­er, on a me­dia call Thurs­day, CFO Karsten Munk Knud­sen said that the re­stric­tion on starter dos­es may be ex­tend­ed for the “com­ing quar­ters.” De­mand is so high, he said, that there is “in­her­ent un­cer­tain­ty to the pace of the obe­si­ty care mar­ket ex­pan­sion.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER